| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.16 | 0.007 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.098 | 0.05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.087 | 0.09 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.075 | 0.1 |